Share Name Share Symbol Market Type Share ISIN Share Description
Amryt Pharma Plc LSE:AMYT London Ordinary Share GB00BKLTQ412 ORD 6P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.0% 124.50 122.00 127.00 124.50 124.50 124.50 932 08:00:00
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 13.0 -23.1 -8.4 - 192

Amryt Pharma Share Discussion Threads

Showing 4801 to 4818 of 5375 messages
Chat Pages: Latest  203  202  201  200  199  198  197  196  195  194  193  192  Older
DateSubjectAuthorDiscuss
30/7/2019
20:31
PMSL. ROFLMAO. Okay, chica1. We've got the message! So you're doing your own single patient AP101 phase III trial. It's a shame that AMYT are conducting a phase III AP101 trial with circa 200 patients in different locations. How very wasteful of AMYT. They could have done a single patient phase III trial like yours and saved a fortune! PMSL ROFLMAO. 16 posts since you joined ADVFN in February of this year. All negative and all on AMYT. Don't you have any interest in other shares? How very strange!
papillon
30/7/2019
17:56
Got our hands on some Episalvan again. Skin conditions tend to flair up in hot an clammy weather. We're not seeing ground breaking results.
chica1
24/7/2019
10:18
RNS targets early Q4 for re admission to AIM
alphabravo321
22/7/2019
08:04
thank you. Do we have any guestimate day for re-listing on AIM?
medicman1
20/7/2019
22:49
mdalos1 20 Jul '19 - 13:23 - 4684 of 4685 0 0 0 LOLs !! Nearly there now then... next step is realising approx. a 65% loss, unless a relatively brief opportunity to sell in the UK AIM Market avails itself before all instruments have been exercised and all Business deals are closed, with the consequences eventually hitting home hard. >>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>> So Nostradamus is predicting I will suffer a 65% loss on my AMYT shares. He obviously needs a new crystal ball as his present one is leading him astray. I'm hopeful that by listing on Nasdaq AMYT will receive the recognition it has sadly lacked on AIM. Biotechs are invariably much higher rated on Nasdaq than AIM.
papillon
20/7/2019
12:43
Whoops Madloss.... forgot to take your olanzapine & resperidone tablets this morning? When you remember... you will likely start erasing your postings again! LOL!
diamondstar1
20/7/2019
10:12
Thanks for clarifying that, Strangeman. I was mystified, but then I have an excuse; I'm old. Apart from reading and posting on some ADVFN message boards I never use social media. Regarding LOL, I remember years ago David Cameron thought it meant "Lots of Love" when corresponding to his then horse riding pal, Rebekah Brooks.
papillon
19/7/2019
15:21
"4 chars"?????????????????????????????
papillon
19/7/2019
12:22
same as the last 4 chars of your post. Another waste of bandwidth
strangeman
19/7/2019
09:07
Yes, many thanks, alphabravo321, for posting that link. I also concur with delta0091. AMYT do appear to have got a bargain. Let's hope investors agree when AMYT relists on AIM and lists on NASDAQ. I was too late to read mdalos's words of wisdom as he'd already deleted his post by the time I looked at this bb. Did I miss much? LOL.
papillon
18/7/2019
20:28
thanks alphabravo
bermudashorts
18/7/2019
14:48
I have the exact same view!
alphabravo321
18/7/2019
13:46
if a fund manager had objection to the deal then it speaks volumes - they felt AMYT had got the acquisition on the cheap. AMYT seems to have pulled off a blinder here taking advantage of historical baggage affecting the company, yet buying a perfectly sound company.
delta0091
17/7/2019
21:29
ADVFN wont allow your link to be accessed. I changed the tt to TT hTTps://www.globenewswire.com/news-release/2019/07/16/1883725/0/en/Novelion-Therapeutics-Announces-Dismissal-of-Whitefort-Capital-Petition.html
papillon
17/7/2019
19:59
https://www.globenewswire.com/news-release/2019/07/16/1883725/0/en/Novelion-Therapeutics-Announces-Dismissal-of-Whitefort-Capital-Petition.html
alphabravo321
17/7/2019
11:05
medicman. I've just looked at my broker nominee a/c (I only have one share, AMYT) and they have increased the value of each of my AMYT shares to 73.5p following on from the one for six consolidation.
papillon
15/7/2019
22:47
mdalos1 15 Jul '19 - 17:38 - 4669 of 4669 0 0 0 Gone down by a sixth or to a sixth ? >>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>> He must mean the latter, mdalos. His "overall value" is just a sixth of what it originally was. medicman is inaccurate in his use of language. Nominee broker a/c's suffer from the same problem as sites like ADVFN with Mkt Caps when there is a share consolidation. They take time (sometimes ADVFN never does) to adjust their value and Mkt Cap figures.
papillon
15/7/2019
09:04
thanks for this! yes I can see that I now have fewer shares but my dealing account also tells me that my overall value has gone down by a sixth too...I guess this is a system issue that might be rectified once reinstated
medicman1
Chat Pages: Latest  203  202  201  200  199  198  197  196  195  194  193  192  Older
Your Recent History
LSE
AMYT
Amryt Phar..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20200127 09:33:38